BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11126166)

  • 41. Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand.
    Perksanusak T; Sananpanichkul P; Chirdchim W; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(12):4977-80. PubMed ID: 26163625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
    Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
    Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Incidence and Clinical Significance of Atypical Glandular Cells of Undetermined Significance on Cervical Pap Smears.
    Al-Rayyan E; Rashed M; Maaita M; Qudah S; Taso O; Haddadin W
    Gulf J Oncolog; 2019 May; 1(30):52-56. PubMed ID: 31242982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP].
    Ben Aissa R; Bennour R; Ben Hamida A; Kammoun N; Mansour H; Mhamdi A; Landoulsi S; Cherif N; Gueddana N
    Tunis Med; 2002 Apr; 80(4):203-6. PubMed ID: 12416356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic loop electrosurgical excisional procedure for discrepancy: do preoperative factors predict presence of significant cervical intraepithelial neoplasia?
    Matthews KS; Rocconi RP; Case AS; Estes JM; Straughn JM; Huh WK
    J Low Genit Tract Dis; 2007 Apr; 11(2):69-72. PubMed ID: 17415109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical value of repeat Pap smear at the time of colposcopy.
    Zardawi IM; Rode JW
    Acta Cytol; 2002; 46(3):495-8. PubMed ID: 12040643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
    Mannino JR
    J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison between reference oncologic colpocytology and severity of intraepithelial cervical lesions].
    Lapin GA; Derchain SF; Tambascia J
    Rev Saude Publica; 2000 Apr; 34(2):120-5. PubMed ID: 10881146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital.
    Khaengkhor P; Mairaing K; Suwannarurk K; Thaweekul Y; Poomtavorn Y; Pattaraarchachai J; Bhamarapravatana K
    J Med Assoc Thai; 2011 Feb; 94(2):152-8. PubMed ID: 21534360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
    Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
    Tunis Med; 2016 Oct; 94(8-9):616-620. PubMed ID: 28685798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.
    Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Howard M; Roth P; Lorincz AT; Gafni A; Walter SD
    Arch Pathol Lab Med; 2003 Sep; 127(9):1169-75. PubMed ID: 12946228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
    Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microcolposcopy vs colposcopy in evaluating abnormal Pap smear. Comparison with histological findings.
    Framarino dei Malatesta ML; Carraro C; Silvestrini I; Marzetti L; Vecchione A
    Clin Exp Obstet Gynecol; 1993; 20(4):236-40. PubMed ID: 8281705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
    Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 60. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.